Tiziana Life Sciences cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 16 quarters of results from Jun 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Activities | ||||||||||||||||
| Change in Capital Stock | ||||||||||||||||
| Shares Issued | 0.05M | 0.11M | 0.47M | 0.42M | 3.06M | |||||||||||
| Misc. | ||||||||||||||||
| Beginning Cash Balance | 0.07M | 0.06M | 5.36M | 5.36M | 0.19M | 65.82M | 65.82M | 42.19M | 42.19M | 18.12M | 18.12M | 1.18M | 1.18M | 3.72M |